Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2010 4
2011 2
2012 3
2013 2
2014 5
2015 5
2016 3
2017 1
2018 4
2019 2
2020 3
2021 1
2022 5
2023 10
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop.
Hua Y, Vella G, Rambow F, Allen E, Antoranz Martinez A, Duhamel M, Takeda A, Jalkanen S, Junius S, Smeets A, Nittner D, Dimmeler S, Hehlgans T, Liston A, Bosisio FM, Floris G, Laoui D, Hollmén M, Lambrechts D, Merchiers P, Marine JC, Schlenner S, Bergers G. Hua Y, et al. Among authors: schlenner s. Cancer Cell. 2022 Dec 12;40(12):1600-1618.e10. doi: 10.1016/j.ccell.2022.11.002. Epub 2022 Nov 23. Cancer Cell. 2022. PMID: 36423635 Free PMC article.
Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.
Whyte CE, Singh K, Burton OT, Aloulou M, Kouser L, Veiga RV, Dashwood A, Okkenhaug H, Benadda S, Moudra A, Bricard O, Lienart S, Bielefeld P, Roca CP, Naranjo-Galindo FJ, Lombard-Vadnais F, Junius S, Bending D, Ono MM, Hochepied T, Halim TYF, Schlenner S, Lesage S, Dooley J, Liston A. Whyte CE, et al. Among authors: schlenner s. J Exp Med. 2022 Jul 4;219(7):e20212391. doi: 10.1084/jem.20212391. Epub 2022 Jun 14. J Exp Med. 2022. PMID: 35699942 Free PMC article.
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".
Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner SM. Lykhopiy V, et al. Among authors: schlenner sm. Genes Immun. 2023 Oct;24(5):248-262. doi: 10.1038/s41435-023-00221-y. Epub 2023 Sep 23. Genes Immun. 2023. PMID: 37741949 Free PMC article. Review.
Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells.
Sprooten J, Vanmeerbeek I, Datsi A, Govaerts J, Naulaerts S, Laureano RS, Borràs DM, Calvet A, Malviya V, Kuballa M, Felsberg J, Sabel MC, Rapp M, Knobbe-Thomsen C, Liu P, Zhao L, Kepp O, Boon L, Tejpar S, Borst J, Kroemer G, Schlenner S, De Vleeschouwer S, Sorg RV, Garg AD. Sprooten J, et al. Among authors: schlenner s. Cell Rep Med. 2024 Jan 16;5(1):101377. doi: 10.1016/j.xcrm.2023.101377. Cell Rep Med. 2024. PMID: 38232703 Free PMC article.
The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program.
Burton OT, Bricard O, Tareen S, Gergelits V, Andrews S, Biggins L, Roca CP, Whyte C, Junius S, Brajic A, Pasciuto E, Ali M, Lemaitre P, Schlenner SM, Ishigame H, Brown BD, Dooley J, Liston A. Burton OT, et al. Among authors: schlenner sm. Immunity. 2024 Jul 9;57(7):1586-1602.e10. doi: 10.1016/j.immuni.2024.05.023. Epub 2024 Jun 18. Immunity. 2024. PMID: 38897202 Free article.
Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development.
Yilmazer A, Zevla DM, Malmkvist R, Rodríguez CAB, Undurraga P, Kirgin E, Boernert M, Voehringer D, Kershaw O, Schlenner S, Kretschmer K. Yilmazer A, et al. Among authors: schlenner s. Front Immunol. 2023 Dec 18;14:1298938. doi: 10.3389/fimmu.2023.1298938. eCollection 2023. Front Immunol. 2023. PMID: 38164128 Free PMC article.
Homozygous DBF4 mutation as a cause of severe congenital neutropenia.
Willemsen M, Barber JS, Nieuwenhove EV, Staels F, Gerbaux M, Neumann J, Prezzemolo T, Pasciuto E, Lagou V, Boeckx N, Filtjens J, De Visscher A, Matthys P, Schrijvers R, Tousseyn T, O'Driscoll M, Bucciol G, Schlenner S, Meyts I, Humblet-Baron S, Liston A. Willemsen M, et al. Among authors: schlenner s. J Allergy Clin Immunol. 2023 Jul;152(1):266-277. doi: 10.1016/j.jaci.2023.02.016. Epub 2023 Feb 24. J Allergy Clin Immunol. 2023. PMID: 36841265 Free article.
Necroptosis in Immuno-Oncology and Cancer Immunotherapy.
Sprooten J, De Wijngaert P, Vanmeerbeerk I, Martin S, Vangheluwe P, Schlenner S, Krysko DV, Parys JB, Bultynck G, Vandenabeele P, Garg AD. Sprooten J, et al. Among authors: schlenner s. Cells. 2020 Aug 1;9(8):1823. doi: 10.3390/cells9081823. Cells. 2020. PMID: 32752206 Free PMC article. Review.
Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy.
Vanmeerbeek I, Naulaerts S, Sprooten J, Laureano RS, Govaerts J, Trotta R, Pretto S, Zhao S, Cafarello ST, Verelst J, Jacquemyn M, Pociupany M, Boon L, Schlenner SM, Tejpar S, Daelemans D, Mazzone M, Garg AD. Vanmeerbeek I, et al. Among authors: schlenner sm. Sci Adv. 2024 Jul 19;10(29):eadm8660. doi: 10.1126/sciadv.adm8660. Epub 2024 Jul 19. Sci Adv. 2024. PMID: 39028818 Free PMC article.
53 results